Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 26 | 2023 | 1942 | 2.290 |
Why?
|
| Brain | 24 | 2023 | 1689 | 2.050 |
Why?
|
| Transcriptome | 9 | 2023 | 83 | 1.870 |
Why?
|
| Proteomics | 6 | 2022 | 91 | 1.250 |
Why?
|
| Gene Expression Profiling | 4 | 2023 | 153 | 1.200 |
Why?
|
| Algorithms | 4 | 2023 | 400 | 1.160 |
Why?
|
| Cognitive Dysfunction | 12 | 2022 | 938 | 1.130 |
Why?
|
| Gene Regulatory Networks | 5 | 2020 | 33 | 1.050 |
Why?
|
| Proteome | 3 | 2022 | 39 | 1.040 |
Why?
|
| RNA, Messenger | 3 | 2022 | 323 | 1.020 |
Why?
|
| Cluster Analysis | 2 | 2023 | 52 | 0.790 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 284 | 0.730 |
Why?
|
| Nerve Net | 2 | 2019 | 54 | 0.730 |
Why?
|
| Dementia | 2 | 2022 | 521 | 0.700 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2023 | 441 | 0.590 |
Why?
|
| Models, Neurological | 1 | 2016 | 30 | 0.570 |
Why?
|
| Genome-Wide Association Study | 6 | 2023 | 301 | 0.570 |
Why?
|
| Models, Theoretical | 1 | 2015 | 91 | 0.530 |
Why?
|
| DNA Methylation | 5 | 2022 | 124 | 0.520 |
Why?
|
| Foot Deformities | 1 | 2014 | 1 | 0.510 |
Why?
|
| Myofascial Pain Syndromes | 1 | 2014 | 1 | 0.510 |
Why?
|
| Pyridoxal Phosphate | 1 | 2014 | 1 | 0.510 |
Why?
|
| Aged, 80 and over | 17 | 2022 | 4851 | 0.510 |
Why?
|
| Humans | 41 | 2023 | 29337 | 0.510 |
Why?
|
| Quantitative Trait Loci | 5 | 2021 | 61 | 0.500 |
Why?
|
| Aging | 8 | 2023 | 1593 | 0.490 |
Why?
|
| Gene Expression | 5 | 2023 | 226 | 0.490 |
Why?
|
| Microglia | 5 | 2023 | 124 | 0.460 |
Why?
|
| Genome, Human | 3 | 2018 | 49 | 0.440 |
Why?
|
| Cognition | 6 | 2021 | 1277 | 0.430 |
Why?
|
| Aged | 19 | 2023 | 9448 | 0.420 |
Why?
|
| Cerebral Cortex | 3 | 2019 | 195 | 0.390 |
Why?
|
| Genotype | 4 | 2019 | 405 | 0.390 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 3 | 2019 | 27 | 0.390 |
Why?
|
| Hormones | 1 | 2010 | 13 | 0.380 |
Why?
|
| Male | 22 | 2022 | 15621 | 0.370 |
Why?
|
| Depressive Disorder, Major | 2 | 2010 | 107 | 0.370 |
Why?
|
| Female | 21 | 2022 | 16197 | 0.360 |
Why?
|
| Amyloid beta-Peptides | 6 | 2021 | 294 | 0.350 |
Why?
|
| Autopsy | 6 | 2019 | 335 | 0.350 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 74 | 0.330 |
Why?
|
| Apolipoprotein E4 | 3 | 2019 | 227 | 0.320 |
Why?
|
| Cohort Studies | 8 | 2020 | 1939 | 0.310 |
Why?
|
| Membrane Transport Proteins | 2 | 2017 | 50 | 0.290 |
Why?
|
| Sequence Analysis, RNA | 3 | 2020 | 42 | 0.270 |
Why?
|
| Motor Activity | 2 | 2019 | 369 | 0.270 |
Why?
|
| Phenotype | 4 | 2023 | 355 | 0.260 |
Why?
|
| Benchmarking | 1 | 2023 | 41 | 0.240 |
Why?
|
| Apolipoproteins E | 3 | 2020 | 230 | 0.220 |
Why?
|
| Multifactorial Inheritance | 2 | 2019 | 24 | 0.220 |
Why?
|
| HSP27 Heat-Shock Proteins | 2 | 2019 | 19 | 0.220 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 152 | 0.220 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 26 | 0.210 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 86 | 0.210 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 173 | 0.210 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 41 | 0.210 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 8 | 0.210 |
Why?
|
| Mutation | 2 | 2014 | 383 | 0.210 |
Why?
|
| Astrocytes | 2 | 2020 | 122 | 0.210 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2020 | 104 | 0.210 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 16 | 0.200 |
Why?
|
| Models, Genetic | 3 | 2020 | 35 | 0.200 |
Why?
|
| Haplotypes | 2 | 2020 | 61 | 0.200 |
Why?
|
| Membrane Proteins | 2 | 2020 | 173 | 0.200 |
Why?
|
| Neurons | 4 | 2021 | 374 | 0.200 |
Why?
|
| Neurofibrillary Tangles | 2 | 2019 | 181 | 0.200 |
Why?
|
| RNA Splicing Factors | 1 | 2020 | 5 | 0.190 |
Why?
|
| Peptides | 1 | 2021 | 95 | 0.190 |
Why?
|
| Cognitive Reserve | 1 | 2020 | 37 | 0.190 |
Why?
|
| Genetic Variation | 2 | 2018 | 105 | 0.180 |
Why?
|
| Central Nervous System Agents | 1 | 2019 | 8 | 0.180 |
Why?
|
| Drug Discovery | 1 | 2019 | 20 | 0.180 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 216 | 0.180 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 20 | 0.180 |
Why?
|
| Movement Disorders | 1 | 2021 | 141 | 0.180 |
Why?
|
| Histones | 1 | 2019 | 28 | 0.180 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 7 | 0.180 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 14 | 0.180 |
Why?
|
| Independent Living | 2 | 2019 | 281 | 0.170 |
Why?
|
| Seasons | 1 | 2018 | 31 | 0.170 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 14 | 0.170 |
Why?
|
| Neuroimaging | 1 | 2019 | 136 | 0.160 |
Why?
|
| Frontal Lobe | 1 | 2018 | 81 | 0.160 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2019 | 115 | 0.160 |
Why?
|
| Brain Infarction | 1 | 2017 | 74 | 0.150 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 17 | 0.150 |
Why?
|
| Homozygote | 1 | 2017 | 23 | 0.150 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 254 | 0.150 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 132 | 0.150 |
Why?
|
| Postural Balance | 1 | 2018 | 121 | 0.150 |
Why?
|
| Risk Factors | 6 | 2019 | 2443 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 1221 | 0.150 |
Why?
|
| Lewy Bodies | 4 | 2019 | 195 | 0.140 |
Why?
|
| Inflammation | 1 | 2018 | 344 | 0.140 |
Why?
|
| tau Proteins | 3 | 2021 | 202 | 0.130 |
Why?
|
| Schiff Bases | 1 | 2014 | 1 | 0.130 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 1 | 0.130 |
Why?
|
| Vitamin B 12 | 1 | 2014 | 7 | 0.130 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 20 | 0.130 |
Why?
|
| Exercise | 1 | 2019 | 468 | 0.120 |
Why?
|
| Fibromyalgia | 1 | 2014 | 29 | 0.120 |
Why?
|
| Mitochondria | 1 | 2014 | 78 | 0.120 |
Why?
|
| Gait | 1 | 2018 | 404 | 0.120 |
Why?
|
| Neuropsychological Tests | 4 | 2019 | 1251 | 0.120 |
Why?
|
| Behavior | 1 | 2013 | 27 | 0.110 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 34 | 0.110 |
Why?
|
| Amygdala | 2 | 2010 | 50 | 0.110 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2013 | 28 | 0.110 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 101 | 0.110 |
Why?
|
| Linear Models | 3 | 2018 | 254 | 0.110 |
Why?
|
| Mice | 4 | 2020 | 1607 | 0.100 |
Why?
|
| Animals | 5 | 2020 | 4552 | 0.100 |
Why?
|
| Brain Chemistry | 1 | 2010 | 47 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 1442 | 0.090 |
Why?
|
| Alleles | 2 | 2021 | 224 | 0.090 |
Why?
|
| Homeostasis | 1 | 2010 | 82 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 391 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 306 | 0.080 |
Why?
|
| Sclerosis | 2 | 2019 | 68 | 0.080 |
Why?
|
| Schizophrenia | 2 | 2018 | 77 | 0.080 |
Why?
|
| Hippocampus | 2 | 2019 | 274 | 0.070 |
Why?
|
| Biomarkers | 2 | 2020 | 689 | 0.070 |
Why?
|
| Species Specificity | 2 | 2020 | 70 | 0.070 |
Why?
|
| Bayes Theorem | 2 | 2015 | 39 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2023 | 14 | 0.060 |
Why?
|
| Meninges | 1 | 2023 | 6 | 0.060 |
Why?
|
| Base Sequence | 1 | 2023 | 134 | 0.060 |
Why?
|
| DNA | 1 | 2023 | 125 | 0.060 |
Why?
|
| Organ Size | 1 | 2023 | 107 | 0.060 |
Why?
|
| Macrophages | 1 | 2023 | 128 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 724 | 0.050 |
Why?
|
| RNA | 1 | 2022 | 39 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 7 | 0.050 |
Why?
|
| Computational Biology | 1 | 2020 | 23 | 0.050 |
Why?
|
| Individuality | 1 | 2020 | 22 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2020 | 47 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2020 | 17 | 0.050 |
Why?
|
| Lysosomes | 1 | 2020 | 24 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 108 | 0.050 |
Why?
|
| Pharmacology | 1 | 2019 | 2 | 0.050 |
Why?
|
| Systems Biology | 1 | 2019 | 7 | 0.050 |
Why?
|
| Acetylation | 1 | 2019 | 13 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 248 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 788 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2020 | 105 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2020 | 132 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2018 | 18 | 0.040 |
Why?
|
| Metabolomics | 1 | 2018 | 23 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 17 | 0.040 |
Why?
|
| Metabolome | 1 | 2018 | 16 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 144 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 638 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 14 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 50 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 116 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2019 | 81 | 0.040 |
Why?
|
| Heterozygote | 1 | 2018 | 103 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 11 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 12 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 37 | 0.040 |
Why?
|
| Epigenomics | 1 | 2017 | 12 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 148 | 0.040 |
Why?
|
| Accelerometry | 1 | 2018 | 87 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 9823 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2017 | 65 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 87 | 0.040 |
Why?
|
| Logistic Models | 1 | 2018 | 407 | 0.040 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 10 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 127 | 0.040 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 113 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2018 | 216 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2018 | 219 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2018 | 330 | 0.040 |
Why?
|
| Chicago | 1 | 2019 | 865 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2021 | 1811 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2015 | 14 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 34 | 0.030 |
Why?
|
| Amyloid | 1 | 2015 | 53 | 0.030 |
Why?
|
| Adult | 2 | 2023 | 8601 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 29 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 959 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 53 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 358 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2015 | 152 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 496 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 75 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1830 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2018 | 1011 | 0.020 |
Why?
|
| United States | 1 | 2017 | 2333 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 58 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2009 | 22 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2018 | 1164 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 263 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 100 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 495 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2009 | 246 | 0.020 |
Why?
|